Antibody-based pharmaceuticals resource

Chronic Rejection Driven by Complement-Mediated Microvascular Damage II


Listen Later

Creative Biolabs introduces topics from functional and molecular descriptions of complement targets to development of complement-directed inhibitors and puts them in a podcast column for interested researchers.

...more
View all episodesView all episodes
Download on the App Store

Antibody-based pharmaceuticals resourceBy Creative Biolabs